Southport Capital Management’s Biogen BIIB Stock Holding History

Southport Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,233	Closed	-$349K	–	331
2021 Q3	$349K	Hold	1,233	–	–	0.14%	164
2021 Q2	$427K	Buy	1,233 +80	+7%	+$24.2K	0.11%	194
2021 Q1	$323K	Sell	1,153 -23	-2%	-$6.2K	0.08%	220
2020 Q4	$288K	Hold	1,176	–	–	0.1%	172
2020 Q3	$334K	Hold	1,176	–	–	0.13%	164
2020 Q2	$315K	Buy	1,176 +23	+2%	+$6.91K	0.13%	154
2020 Q1	$365K	Sell	1,153 -32	-3%	-$9.71K	0.19%	120
2019 Q4	$352K	Sell	1,185 -27	-2%	-$7.49K	0.14%	146
2019 Q3	$282K	Buy	+1,212	New	+$282K	0.13%	160
2018 Q4	–	Sell	-635	Closed	-$224K	–	198
2018 Q3	$224K	Sell	635 -185	-23%	-$63.7K	0.1%	163
2018 Q2	$238K	Hold	820	–	–	0.11%	158
2018 Q1	$225K	Sell	820 -100	-11%	-$31K	0.1%	177
2017 Q4	$293K	Buy	+920	New	+$295K	0.11%	176

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Southport Capital Management's BIIB Position: Q4 2021 in Review

Southport Capital Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 1,233 shares — an estimated $349K sold.

Southport Capital Management first reported a position in BIIB in Q4 2017 and held it in 13 quarters. The position peaked at $427K in Q2 2021. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Southport Capital Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Southport Capital Management sold 1,233 Biogen shares in Q4 2021, an estimated $349K.
Southport Capital Management first reported a position in Biogen in Q4 2017 and held it in 13 quarters.
Southport Capital Management's Biogen position peaked at $427K in Q2 2021.
1,010 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Southport Capital Management's 13F filing for Q4 2021, filed 27 Jan 2022.